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Abstract
Background: Although heart disease is a major cause of morbidity and mortality the majority of
patients do not access existing rehabilitation programs and patient resources are not designed to
facilitate patient choice and decision-making. The objective of this study was to develop and test a
series of risk factor modules and corresponding patient information leaflets for secondary
prevention of CHD.
Methods: In phase one, a series of risk factor modules and management options were developed
following analysis of literature and interviews with health professionals. In phase two, module
information leaflets were developed using published guidelines and interviews of people with CHD.
In phase three, the leaflets were tested for quality (DISCERN), readability (Flesch) and suitability
(SAM) and were compared to the existing cardiac rehabilitation (CR) information leaflet. Finally,
the patients assessed the leaflets for content and relevance.
Results: Four key risk factors identified were cholesterol, blood pressure, smoking and physical
inactivity. Choice management options were selected for each risk factor and included medical
consultation, intensive health professional led program, home program and self direction. Patient
information needs were then identified and leaflets were developed. DISCERN quality scores were
high for cholesterol (62/80), blood pressure (59/80), smoking (62/80) and physical activity (62/80),
all scoring 4/5 for overall rating. The mean Flesch readability score was 75, representing "fairly easy
to read", all leaflets scored in the superior category for suitability and were reported to be easy to
understand, useful and motivating by persons with CHD risk factors. The developed leaflets scored
higher on each assessment than the existing CR leaflets.
Conclusion: Using a progressive three phase approach, a series of risk factor modules and
information leaflets were successfully developed and tested. The leaflets will contribute to shared-
decision making and empowerment for persons with CHD.
Background
Coronary heart disease (CHD) is a chronic illness that is
best managed when positive health behaviors become
integrated into long-term lifestyle habits [1]. Secondary
prevention of CHD involves risk factor reduction through
control of health behaviors such as diet, physical activity,
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smoking and medication adherence using a coordinated
approach and referrals to health professionals [2,3]. Mod-
ification of risk factors such as blood cholesterol, blood
pressure (BP), physical inactivity, smoking, overweight,
diabetes and depression can reduce cardiovascular events,
the need for coronary revascularisation and improve qual-
ity of life (QOL) [4]. However, strategies are needed to
motivate patients to consistently follow multidimen-
sional treatment regimens [1].
Although attendance at cardiac rehabilitation (CR) pro-
grams is widely recommended [5,6] there is significant
under-use of facility-based programs in Australia [7,8]
and internationally [9-11]. Despite clear short-term bene-
fits for attendees, large groups of patients are not access-
ing, which presents an opportunity and challenge to
improve CHD care [10]. Although many authors have
suggested the need for development of alternative models,
these have not yet been widely described or implemented.
One pilot study investigated secondary prevention of
CHD using a 'modular' approach [12]. For the study, a
metropolitan cardiac rehabilitation program was offered
as individual components, or modules, based on patient
need rather than an all-or-nothing exercise-based
approach. Although only 26 subjects participated, the
study demonstrated enhanced completion rates and cost
effectiveness. The pilot study was an important step from
standard cardiac rehabilitation however, modules were
still conducted in a group environment and were based on
education without formal goal setting and follow-up and
no patient information leaflets were provided. Results of
the pilot study suggest that development and evaluation
of more detailed unique risk factor modules may enhance
long-term outcomes.
The development of patient resources based on multidi-
mensional behavior modification techniques may
enhance compliance with long-term risk factor interven-
tions [13]. Techniques include goal setting, choice and
offering a wide range of individually-tailored services [6].
For chronic disease, change needs to be conceptualised in
a positive light to reduce anxiety rather than focusing on
negative aspects of making a change [1]. Setting of mutu-
ally-agreed and realistic goals with clear time-frames
enhances active patient orientation and motivation which
facilitates behavior change [1,14]. The inclusion of a con-
fidence rating for goal achievement may improve the
health professional's insight into a patient's motivation to
change [1].
Offering choice, in situations where there are several man-
agement options, based on individual need and prefer-
ence is a further method of enhancing active patient
orientation [15]. It is also suggested that options offered
as a menu of strategies are more successful because it
encourages each patient's task to be one of "choosing
rather than refuting" [1]. Providing choice allows different
people to respond to health professionals in different
ways based on each persons needs at different times. We
have chosen the term 'guided self-choice' to describe this
model which creates a collaborative encounter, which is
similar to the spirit of behavior counseling [16].
Facilitation of collaborative relationships, shared deci-
sion-making and communication of expectations in a
supportive environment helps motivate behavior change
and contribute to the disease management process
[17,18]. Formation of collaborative relationships
decreases patient anxiety and dissatisfaction that is often
related to uncertainty and lack of information, explana-
tion and feedback [19]. Studies have demonstrated that
encouraging patients to participate in treatment decisions
improves health status, QOL [20,21], satisfaction, compli-
ance and treatment outcomes [22]. More specifically,
patients with a higher degree of active orientation are
more likely to comply with treatment recommendations
for BP [18], diabetes and physical activity [23].
Although provision of effective education is an essential
component of healthcare [24], patients tend to forget
approximately half the information provided [25]. Pro-
viding supplementary written information increases
patients' knowledge of disease [26-28] and reduces dis-
tress [29] and decisional conflict [30] because it reinforces
verbal instructions and serves as a home resource [31].
Effective patient information must be evidence-based,
clearly presented and most importantly, involve patients
throughout the process of development [32-34]. Informa-
tion materials should succinctly deal with the relevant
messages [31] be written in active voice with personalised
messages and use simple terminology [14,31,35]. Layout
should be clear, simple and consistent [14,35] and use
subheadings to allow patients to efficiently sift through
the information [17,31].
Various studies have tested patient education materials
including those for drug information [36,37], prostate
cancer [38], asthma [39], cardiac catheterization [40] and
about general practice [41]. Two studies have highlighted
the importance of devoting considerable effort to the
development of educational materials and including
patients throughout the entire process [42,43]. Both stud-
ies used a progressive approach and demonstrated that if
a leaflet is written at an easily readable level and in collab-
oration with patients, knowledge is increased. The objec-
tives of this study were to develop and evaluate a series of
cardiac risk factor modules and corresponding informa-
tion leaflets for secondary prevention of CHD.BMC Health Services Research 2006, 6:95 http://www.biomedcentral.com/1472-6963/6/95
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Methods
Phase 1 – Development of secondary prevention risk factor 
modules
The objective of phase one was to develop a series of CHD
secondary prevention risk factor modules each containing
a menu of management options. Major CHD risk factors
were identified after a systematic search of electronic data-
bases and cross-reference of publications for consistent
risk factors that put the greatest proportion of patients at
the highest risk. In addition, six health professionals
including allied health, medical and nursing, were inter-
viewed about risk factors and their prevention. They were
specifically asked which risk factors were the most preva-
lent, which presented the greatest CHD risk.
Once key risk factors were identified, the authors con-
ducted an investigation of the relevant and available man-
agement options within the area health service. Key areas
included the availability of lipid clinics, smoking cessa-
tion programs and local exercise and walking groups.
Searches were conducted via internet searches, telephone
contacts with health professionals and in person. Contact
details, general information and costs, if applicable, for
each service were recorded.
Phase 2 – Development of module information leaflets
The objective of phase two was to develop information
leaflets for each of the modules, developed in phase 1,
using published guidelines [10]. Semi-structured inter-
views of volunteers with at least one CHD risk factor were
also conducted to identify their feedback for the leaflets
along with ideas to enhance motivation for behavior
change. Potential volunteers were identified consecutively
from an outpatient clinic at a local hospital, were between
30–60 years and had least one of the relevant CHD risk
factors.
Each interview was guided with a series of seven pre-devel-
oped questions which focused on the type and volume of
information people would like about CHD risk factors
and what information would be motivating. All partici-
pants were also asked if they wanted to be involved in the
management decision-making and the interview was con-
cluded with an open question asking for any further com-
ments.
After systematically addressing each of the published
guidelines [17] and using themes generated from inter-
views of health professionals and people with CHD risk
factors, the module information leaflets were drafted.
Apart from a heading and relevant logos, additional space
was provided for documenting the risk factor level, goal,
time frame for achievement and information about the
nationally recommended level. The front page also
included a series of options, each with a 'tick box', from
which the patient could choose a single preferred manage-
ment option. Each information leaflet also included gen-
eral information about CHD, suggestions for reducing the
risk factor and space for documenting phone numbers
and appointment details. A point-form layout with size
12 font in an A5 size book format was chosen for ease of
reading and visual appeal.
Phase 3 – Testing of module information leaflets
The objective of phase three was to evaluate the module
information leaflets for quality, readability and suitability
and content and relevance. The newly developed leaflets
were also compared to the existing CR information leaflet
that was obtained from the rehabilitation coordinator.
Two independent researchers completed all assessment
tools for each leaflet and the mean scores were calculated
for each subsection.
Quality of the leaflets was evaluated using the DISCERN
instrument [44] which is a 16 item questionnaire and is a
reliable and valid measure [44-46] with three sections –
reliability of the publication, quality of the information
about treatment choices and overall rating. Each item is
scored on a 5-point Likert scale from one (low quality) to
five (high quality). An aggregate score greater than 75 rep-
resents very high quality and a final score of less than 15
represents very low quality [44].
Readability of the leaflets was evaluated using the Flesch
readability formula which assesses the average number of
syllables per word and the average number of words per
sentence [47]. The final score for reading ease are out of a
possible 100, scores between 70 and 100 represent matter
that is understandable by people who have completed the
fourth grade of schooling [47]. The human interest score
represents the amount of personalisation in the piece of
writing, scores range from zero (no human interest) to
100 (extensive personal interest). The Flesch formula has
been demonstrated to be reliable and highly correlated
with other readability formulae for analysis of health-
based literature [48].
The leaflets were evaluated for suitability using the Suita-
bility Assessment of Materials (SAM) instrument [49]. The
SAM has 22-items that test six criteria of written materials
– content, literacy demand, graphics, presentation, learn-
ing stimulation or motivation and cultural appropriate-
ness. Final aggregate sores greater than 70% are judged to
be superior, scores between 40%–69% are deemed ade-
quate and scores below 40% are considered unsuitable.
The SAM has been validated following evaluation of a
nutritional leaflet by more than 150 health professionals
[49].BMC Health Services Research 2006, 6:95 http://www.biomedcentral.com/1472-6963/6/95
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To evaluate content, relevance and usefulness of the leaf-
lets from a patient's perspective, a group of people with at
least one CHD risk factor completed a questionnaire. The
questionnaire was completed anonymously in the hospi-
tal outpatient clinic and was made up of nine Likert items
across four sections – overall rating, heart disease infor-
mation, treatment options and style and readability. The
questionnaire was designed to obtain opinions on core
attributes previously outlined [17] – content adequacy
(understanding), relevance (a balanced view) and match-
ing of information with the individual's experience (vis-
ual appeal). Readers were asked to rate each question on
a five-point visual analogue scale, higher scores repre-
sented more positive responses. Space was also provided
for comments and identification of words not under-
stood.
A target recruitment rate of 10 participants per risk factor
was set, providing a total of 40 participants across the four
risk factors. Participants were recruited consecutively from
a local hospital clinic and were included if they had at
least one of the relevant CHD risk factor and if they vol-
unteered to review the leaflet. The results for the newly
developed and the existing CR leaflets were compared
using t-tests for continuous variables and chi-squared for
proportions, two-tailed p-values of < 0.05 were consid-
ered significant.
Ethical approval
Ethical approval for the study was provided by the Central
Sydney Area Health Service CRGH Zone and the Univer-
sity of Sydney. Written and informed consent was
obtained from all participants prior to commencement.
Results
Phase 1 – Development of secondary prevention risk factor 
modules
Following literature analysis and interviews with health
professionals, four key CHD risk factors were chosen for
development into modules and corresponding informa-
tion leaflets. The risk factors chosen were cholesterol man-
agement as well as BP-lowering, smoking cessation and
physical inactivity which could be chosen based on need
and preference. High cholesterol was chosen because it is
a very highly prevalent and continuous risk factor where
the higher the value, the higher the risk. In Australia,
about half the adult population have high cholesterol
[50]. Importantly, cholesterol-lowering decreases the rela-
tive risk for major coronary events by 27%, for CHD mor-
tality by 27% and for all cause mortality by 21% [51]. For
these reasons along with the strong recommendation of
the Cardiologist interviewed and based on the secondary
prevention benefit of cholesterol-lowering, it was decided
that cholesterol lowering would be a priority risk factor
module that all patients should be encouraged to partici-
pate in.
High BP was chosen because of its prevalence and the
graded relationship between BP and risk of CHD risk [52].
Approximately 28% of the Australian adult population
have high BP [50]. BP lowering has been found to cause a
12% reduction in cardiovascular events and a 22% reduc-
tion in mortality [53]. Smoking was a chosen key risk fac-
tor because it accounts for approximately 13% of
Australian deaths annually [54]. In addition, smoking ces-
sation has both dose dependent and reversible improve-
ments on endothelial function [55]. Physical activity was
also chosen because 44% of the Australian adult popula-
tion do not participate in a level of physical activity that is
sufficient to achieve a health benefit [54]. In addition,
increasing physical activity levels can have a positive effect
on other risk factors such as cholesterol, BP, overweight,
diabetes and depressed mood [56].
Four common management options were identified were
– medical consultation, a health professional-led inter-
vention, a home program and self help (Table 2). Where
practical, each management option was incorporated into
each module to provide a menu-style choice. For the med-
ical consultation, patients were to be encouraged to initi-
ate contact with their doctor, to record and follow their
advice. For health professional-led intervention, the risk
factor was managed by participation in a supervised,
structured program that may be hospital or community
based. For the home program option, patients were to
manage the risk factor through participation in a home-
based program. Finally, in the self-help option, patients
could choose to manage the risk factor through their own
means and were provided with sources of local informa-
tion including the internet, telephone numbers and
books. At the completion of phase 1, although all patients
were to be encouraged to participate in cholesterol-lower-
ing, each module followed a guided self-choice approach
where patients could choose, in collaboration with a
health professional, the management option to suit their
individual needs or preference.
Phase 2 – Development of module information leaflets
Common themes identified from published guidelines
[17] were that the leaflets should be simple and positive
in design and language, repeat key terms, clearly identify
treatment options and importantly that patients should
be involved throughout development and testing. A group
of 12 people with at least one CHD risk factor volunteered
to be interviewed, nine were male, age ranged from 30–52
years with a mean of 47 years. Seven participants had
experienced previous angina, one had a previous myocar-
dial infarction and three had no previous acute coronary
syndrome (ACS). Common content-related themesBMC Health Services Research 2006, 6:95 http://www.biomedcentral.com/1472-6963/6/95
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included widespread request to have basic information
that provided reassurance as well as realistic and practical
methods for managing the risk factor (Table 1). Partici-
pants suggested the use of a positive and motivating tone,
most felt strongly about the provision of contact details
and the need for space to write questions and all com-
mented on the need for simplicity and brevity.
Of the participants with high cholesterol, 100% wanted to
know their own and the recommended level and 66%
wanted information about cholesterol testing and medi-
cations. Of the participants with high BP, 100% requested
information about the effects of BP on the heart and
about medications for BP. Of the patients who were phys-
ically inactive, 100% expressed a need for simple and
practical information about safe activities. Of the current
smokers interviewed, 100% said they wanted information
about how to quit and none wanted information about
why. For all risk factors, 100% of participants felt strongly
about the need for shared decision-making and tailoring
management to suit their lifestyle.
Phase 3 – Testing of module information leaflets (Table 3 
and Table 4)
The final calculated results relating to leaflet quality, out
of a possible 80, for the DISCERN were 61.5 for blood
cholesterol, 59 for blood pressure, 62 for smoking and
61.5 for physical activity. All leaflets scored 4/5 for overall
rating and the mean results for each of the three key DIS-
CERN sections was calculated (Table 3). Flesch readability
scores for the four leaflets ranged from 68 to 82 with a
mean of 75. The overall score for the combined module
leaflets was 75, placing them in the "fairly easy to read"
category [47]. When tested for suitability, all four module
information leaflets scored greater than an 80% SAM rat-
ing placing them all in the superior category. Compared to
the existing CR information leaflet, the newly developed
module leaflets scored significantly higher on the DIS-
CERN (p = 0.04), Flesch (p = 0.01) and SAM (p < 0.001)
assessment tools.
A total of 40 participants, 10 for each module, tested the
leaflets for content and relevance. Demographic data and
the questionnaire results for each module were summa-
rised, scores were all out of a possible five (Table 4). Gen-
eral suggestions given by participants relating to
presentation and understanding included increasing the
space between the goal and management options, provid-
ing more space to write notes and placing the goal and
measured risk factor in a shaded box to enhance clarity.
Specific comments – "motivates me to lower my choles-
terol", "sufficient information", "easy to understand",
"clear language", "options are clear and in a logical order"
and "providing a variety of options is more motivating
than someone just telling me what to do". One partici-
pant believed the term "cessation" on the smoking leaflet
Table 1: Identified information needs of patients with heart disease
Cholesterol
Information about the recommended level
Information about own cholesterol
Information about how cholesterol causes heart disease
Information about the effect of diet and medication
Frequency of blood testing required
Duration for taking medication
Need to document own cholesterol and date of blood test
Blood pressure (BP)
Basic and easy to understand information about how BP effects the heart
Which medications are for BP
Need space available to record questions and communication with doctor
All claimed it would be motivating if the doctor suggested they decrease their BP
Physical inactivity
Request for flexibility and choice to suit lifestyle
Need for practical and simple information about how activity reduces heart disease
Information about safety and when to stop activity
Duration and frequency of activity
Suggestions such as having a chart (eg, on the fridge) would be motivating
Smoking
None said they need information about why they should stop
Practical suggestions and choice about cessation methods
Don't want to be told what to do
Recommendation from the doctor would be motivating
Information about nicotine patches
All stated that setting a quit date would be helpful
Knowing they were being monitored by a hospital staff member would be motivatingBMC Health Services Research 2006, 6:95 http://www.biomedcentral.com/1472-6963/6/95
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should be changed to "quitting". All changes suggested by
the volunteers were incorporated into the leaflets.
Discussion
This study describes the development and testing of a new
series of CHD risk factor modules and corresponding
information leaflets for patients. From the literature and
input from consumers and health professionals, it was
determined that cholesterol-lowering would be a manda-
tory module and remaining risk factors (BP management,
physical inactivity and smoking cessation) would be
optional modules. A menu of management options was
developed and adapted for each of the risk factors to facil-
itate active choice rather than encourage refuting and scru-
Table 3: Module and existing information leaflet scores for quality, readability and suitability
Blood 
cholesterol 
(mean ± SD)
Blood pressure 
(mean ± SD)
Tobacco 
smoking (mean 
± SD)
Physical activity 
(mean ± SD)
Combined new 
leaflets (mean 
± SD)
Existing CR 
leaflets (mean 
± SD)
p
Quality 
(DISCERN 
instrument)
Reliability† 3.7 ± 1.4 3.5 ± 1.3 3.5 ± 1.4 3.8 ± 1.2 3.6 ± 1.3 2.9 ± 1.9 0.002
Choices† 3.9 ± 1.2 3.8 ± 1.2 4.2 ± 0.9 3.9 ± 1.2 3.9 ± 1.2 2.6 ± 2.0 0.000
Overall 
rating†
4.0 ± 0.0 4.0 ± 0.0 4.0 ± 0.0 4.0 ± 0.0 4.0 ± 0.0 2.0 ± 0.0 0.000
F i n a l  r e s u l t  § 6 1 . 55 9 . 06 2 . 06 1 . 56 0 . 54 3 . 0 -
Readability 
(Flesch)
R e a d i n g  e a s e ‡ 6 87 58 27 77 83 2 0 . 0 1 5
Description standard fairly easy easy fairly easy fairly easy difficult -
Human 
interest *
71 70 70 70 70 4 0.000
Description dramatic dramatic dramatic dramatic dramatic scientific -
Population 
able to 
understand
75% 80% 86% 80% 79% 24% 0.000
Suitability 
(SAM) rating 
**
83% 81% 81% 81% 81% 23% 0.000
SAM = suitability assessment of materials, CR = cardiac rehabilitation.
† scored on a 5-point Likert scale from 1 (low quality) to 5 (high quality).
§scores out of a possible 80 where higher scores represent higher quality.
‡ scores out of a possible 100, higher scores represent greater ease of understanding.
* scores out of a possible 100, higher scores represent higher personal interest.
** sores out of a possible 100, higher scores represent greater suitability.
p = probability of test statistic for difference between the combined new leaflets and the existing CR leaflets
Table 2: Management options for BP, smoking cessation and physical activity
Choice Options BP Management Smoking Cessation Physical Activity
Medical consultation
Follow doctors advice Follow doctors advice Follow doctors advice
Health professional-led 
intervention Group session at local hospital Local hospital dedicated 
program for smoking cessation
Six week supervised group 
exercise
intervention
Outpatient diet review Community group walking 
program
Home program
Home medication, exercise 
program prescribed by doctor and 
allied health professional
Nil relevant Written Home exercise 
program prescribed by allied 
health professional
Self-directed
Heartline Quitline Physical activity resources 
accessed at own discretion
Private dietitian Heartline
Reading, multi-media resources
¾ ¾ ¾
¾ ¾ ¾
¾ ¾
¾ ¾ ¾
¾ ¾ ¾
¾ ¾
¾BMC Health Services Research 2006, 6:95 http://www.biomedcentral.com/1472-6963/6/95
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tinising that often occurs if options are presented one by
one [1].
Development of the risk factor modules was achieved by
interview with health professionals and a systematic
review of management options available in the local area.
After identifying four consistent management options,
each was then tailored for the four chosen risk factors. The
management options included choices where the patient
could take a more passive role and choices where the
patient could take a more independent and active role in
their health-care (self-help). Therefore, the choices within
each module were designed to facilitate a successful out-
come, or risk factor reduction, for a diverse range of per-
sonality types and for patients at different stages since
their original heart event.
The information needs expressed by patients in phase two
compared favourably with the suggestions given in pub-
lished guidelines [17], for example, the need for specific
and honest information, a concise design and the availa-
bility of treatment options. We addressed both process
and content guidelines by involving patients and health
professionals, reviewing clinical evidence and evaluating
the leaflets. Therefore, this study provides an extension
from published guidelines, documents the specific infor-
mation needs of patients with CHD risk factors and high-
lights the importance of identifying patient needs using
interview, as suggested by previous researchers [48].
When tested for quality, all four newly developed module
information leaflets scored ratings greater than 'moderate'
level on the DISCERN instrument. The leaflets were
designed to provide basic information about the risk fac-
tor rather than comprehensive information about heart
disease. All leaflets scored highly on items relating to treat-
ment options, sources of additional information and sup-
port for shared decision-making. This finding confirms
the pre-defined intention of the developed resources, par-
ticularly in terms of shared decision making.
When assessed for readability, the majority of leaflets
scored in the 'fairly easy to read' Flesch category. The mean
Flesch reading ease score for the leaflets was 75, indicating
that 80% of the general population would be expected to
understand it [35]. Many of the polysyllabic words (eg,
blood cholesterol) appeared repetitively in the leaflets
and hence the Flesch score probably underestimated read-
ing ease. Importantly, studies comparing readability and
knowledge, found that a leaflets reading ease was associ-
ated with a significant increase in knowledge [36,41].
The blood cholesterol leaflet scored the lowest readability,
probably because the word 'cholesterol' was repeated nine
times in the 100 word sample assessed. The word 'choles-
terol' represents a four syllable word which would have
adversely affected the Flesch score. Previous authors have
criticised the use of readability formulas because they dis-
regard patients' familiarity with certain words [39].
Importantly, when interviewed, no participants with high
cholesterol identified the 'cholesterol' as a term they did
not understand. A similar scenario existed for the physical
activity leaflet. While the readability score is a useful
objective method of assessing written education material,
the scores do not consider patient motivation, visual
attractiveness and conceptual background of the reader.
Therefore, the score, as suggested by previous authors
[49], was only used as one element for consideration
when developing the written material.
When assessed for suitability, all leaflets scored in the cat-
egory representing 'superior' suitability [57]. Each leaflet
scored similarly because each followed the same basic
style and layout and the SAM is weighted fairly heavily in
terms of these aspects. The main deficiency in each of the
information leaflets was the reading level score. To
achieve the maximum score the reading level had to be of
grade 5 or less. As described previously it is likely that the
module information leaflets scored greater reading age
then grade five due to the repetitive use of polysyllabic
words such as "cholesterol" and "physical activity".
Table 4: Rating of content and relevance of module information leaflets by patients
Blood Cholesterol 
(mean ± SD)
Blood Pressure (mean 
± SD)
Tobacco Smoking 
(mean ± SD)
Physical Activity 
(mean ± SD)
Combined results 
(mean ± SD)
Age (years) 62 ± 21 55 ± 22 59 ± 21 57 ± 19 58 ± 21
% male 40 40 50 50 45
Overall rating † 4.2 ± 0.9 4.3 ± 0.7 4.3 ± 0.7 4.2 ± 0.6 4.3 ± 0.7
Heart disease † 3.6 ± 0.7 4.4 ± 0.7 4.5 ± 0.5 4.4 ± 0.5 4.2 ± 0.7
Treatment options † 4.5 ± 0.6 4.7 ± 0.4 4.7 ± 0.4 4.7 ± 0.4 4.6 ± 0.5
Style and readability † 4.3 ± 0.6 4.4 ± 0.7 4.6 ± 0.5 4.4 ± 0.5 4.4 ± 0.6
†scored on a 5-point Likert scale from 1 (low quality) to 5 (high quality)BMC Health Services Research 2006, 6:95 http://www.biomedcentral.com/1472-6963/6/95
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Compared to the newly developed module leaflets, the
existing CR information leaflets scored poorly on all
assessment tools. The CR leaflets were not dated, did not
provide sources of additional information, presented an
unbalanced view where only treatment was offered and
they did not support shared decision making. Also, the CR
leaflets were written in complex language and passive
voice within minimal personalisation. These findings
highlight the importance of involving patients through-
out the process of development and demonstrate the
superiority of the newly developed module information
leaflets.
High scores for content and relevance suggest that people
with relevant CHD risk factors found them useful and
easy to comprehend. Overall, the cholesterol manage-
ment leaflet tended to score slightly lower which may
reflect the different nature of this module. Being a manda-
tory module, management choices were restricted. In con-
trast, the modules for BP, physical activity and smoking all
had extensive information about treatment choices. The
leaflets tended to score lowest on the section related to
information about CHD but highest on the section about
treatment choices. This finding reflects the aim of the leaf-
lets which was to focus on flexibility and choice rather
than to provide didactic information.
There are various strengths and weaknesses of the progres-
sive approach used in this study. We have documented a
clinically practical method for developing and testing
patient information materials that involved patients and
health professionals throughout. However, only a small
number of participants were involved for each phase and
most did not have severe CHD. As only four key risk fac-
tors were chosen for development into modules and cor-
responding leaflets, future research could investigate
modules and leaflets for all modifiable CHD risk factors.
Also, as the leaflets were only compared to the existing
information leaflet from one cardiac rehabilitation pro-
gram, comparison of the leaflets with patient information
from a diverse range of cardiac rehabilitation programs
would be beneficial.
Conclusion
Using a three phase approach including qualitative and
quantitative research methods, a series of risk factor mod-
ules and corresponding information leaflets have been
developed and tested. Importantly, this study describes a
readily applicable systematic process for designing and
validating written patient information. This study also
documents the unique perspective of persons with CHD
risk factors. The leaflets are now considered suitable for
use in further studies to test the effectiveness of a modular
approach to secondary prevention of CHD and are
expected to contribute to shared-decision making, patient
empowerment and active patient participation.
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